Bcal Diagnostics Ltd - Asset Resilience Ratio

Latest as of June 2023: 0.00%

Bcal Diagnostics Ltd (BDX) has an Asset Resilience Ratio of 0.00% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

AU$8.37 Million

≈ $5.92 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2022)

This chart shows how Bcal Diagnostics Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Bcal Diagnostics Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Bcal Diagnostics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Bcal Diagnostics Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Bcal Diagnostics Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Bcal Diagnostics Ltd Industry Peers by Asset Resilience Ratio

Compare Bcal Diagnostics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%

Annual Asset Resilience Ratio for Bcal Diagnostics Ltd (2021–2022)

The table below shows the annual Asset Resilience Ratio data for Bcal Diagnostics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	AU$0.00 ≈ $0.00	AU$8.37 Million ≈ $5.92 Million	--
2021-12-31	37.77%	AU$4.00 Million ≈ $2.83 Million	AU$10.59 Million ≈ $7.49 Million	--

pp = percentage points

About Bcal Diagnostics Ltd

AU:BDX Australia Diagnostics & Research

Market Cap

$17.48 Million

AU$24.70 Million AUD

Market Cap Rank

#25490 Global

#1103 in Australia

Share Price

AU$0.07

Change (1 day)

-4.29%

52-Week Range

AU$0.05 - AU$0.14

All Time High

AU$0.25